News Release

2022-12-13
Optieum Biotechnologies
Announcement of Research License and Option Agreement with GI CELL
Optieum Biotechnologies Inc., and GI CELL (HQ: Seongnam, Korea / CEO: Dr. Chun Pyo Hong) h[...]
2022-12-13
Optieum Biotechnologies
GI CELL社とResearch License and Option Agreement締結のお知らせ
　このたび、当社はGI CELL社（本社：韓国 城南市、CEO： Dr. Chun Pyo Ho[...]
2022-12-01
Optieum Biotechnologies
Optieum Biotechnologies and National Cancer Center Japan Signed Joint Research Agreement on Solid Tumor Targeting CAR-T Cell Programs
　We are pleased to announce that Optieum Biotechnologies Inc. (“Optieum”) has entere[...]
2022-12-01
Optieum Biotechnologies
国立がん研究センターとの共同研究契約締結のお知らせ
　オプティアム・バイオテクノロジーズ株式会社（愛媛県東温市、[...]